Published in West J Med on July 01, 1991
The digital rectal examination of women. West J Med (1991) 0.75
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med (1987) 6.41
Cancer statistics, 1990. CA Cancer J Clin (1990) 3.97
Latent carcinoma of the prostate. J Pathol Bacteriol (1954) 3.18
Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology (1988) 1.83
Total prostatectomy for clinically localized prostatic cancer: long-term results. J Urol (1989) 1.21
A critical review of adult health maintenance. Part 3: Prevention of cancer. J Fam Pract (1986) 1.20
Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared. Cancer (1985) 1.10
Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urol (1987) 1.08
Adenocarcinoma of the prostate: results of routine urological screening. J Urol (1984) 0.99
Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol (1988) 0.98
The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Engl J Med (1980) 0.94
Histology of the prostate in elderly men. A study in an autopsy series. Acta Pathol Microbiol Scand A (1972) 0.92
Prostate specific antigen. Experimental and clinical observations. Scand J Urol Nephrol Suppl (1987) 0.89
Routine screening for prostate cancer using the digital rectal examination. Prog Clin Biol Res (1988) 0.89
Radiotherapeutic treatment of prostatic carcinoma with pelvic node involvement. Urol Clin North Am (1984) 0.86
Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations. J Urol (1986) 0.86
Cancer of the prostate gland. Results of early diagnosis and therapy undertaken for cure of the disease. JAMA (1971) 0.83
Background for screening--epidemiology and cost effectiveness. Prog Clin Biol Res (1988) 0.81
An evaluation of five tests to diagnose prostate cancer. Prog Clin Biol Res (1987) 0.81
Carcinoma of the prostate: five-year followup of patients treated by radical surgery. J Urol (1956) 0.80
Adenocarcinoma of the prostate gland. Urol Surv (1977) 0.79
Latent carcinoma of the prostate--why the controversy? J Urol (1974) 1.48
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol (1995) 1.47
Total prostatectomy for clinically localized prostatic cancer: long-term results. J Urol (1989) 1.21
Experience with triple-drug therapy in a pharmacological erection program. J Urol (1993) 1.09
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Gracilis muscle flap for closure of rectourethral fistula. J Urol (1979) 1.03
Needle tract seeding following aspiration of renal cell carcinoma. J Urol (1977) 0.99
Total prostatectomy for localized prostatic cancer. J Urol (1984) 0.98
Kidney stone removal: percutaneous versus surgical lithotomy. J Urol (1985) 0.97
Endopyelotomy: review of results and complications. J Urol (1991) 0.94
Experience with indwelling ureteral stent catheters. J Urol (1976) 0.93
Needle tract seeding of renal cell carcinoma. AJR Am J Roentgenol (1977) 0.91
Reno-colic and reno-colic-cutaneous fistula: report of 3 cases. J Urol (1965) 0.90
Primary adenocarcinoma of bladder. Urology (1980) 0.90
Extracorporeal shock-wave lithotripsy for bile duct calculi. Am J Surg (1998) 0.89
Pubovaginal slings using fascia lata for the treatment of intrinsic sphincter deficiency. J Urol (1997) 0.89
Manifestations of renal cell carcinoma. Urology (1976) 0.88
Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol (1993) 0.88
Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol (1986) 0.88
Chemotherapy of advanced prostatic cancer by the National Prostatic Cancer Group. Semin Oncol (1976) 0.88
A new method for percutaneous nephrostomy. Radiology (1976) 0.84
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate. J Urol (1981) 0.83
Mechanical reliability, surgical complications, and patient and partner satisfaction of the modern three-piece inflatable penile prosthesis. Urology (1998) 0.83
Prostate cancer. Chemotherapy. Cancer (1987) 0.83
Microvascular management of multiple renal arteries in transplantation. J Urol (1982) 0.83
Radiation exposure to patient and urologist during percutaneous nephrostolithotomy. J Urol (1984) 0.82
Chemotherapy of advanced prostatic cancer. Evaluation of response parameters. Urology (1976) 0.82
The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. J Urol (1976) 0.82
Total prostatectomy for stage B carcinoma of the prostate. J Urol (1977) 0.81
Adjuvant therapy for localized prostate cancer. Cancer (1993) 0.81
Adjuvant therapy for clinical localized prostate cancer treated with surgery or irradiation. Eur Urol (1996) 0.80
Carcinoma of the prostate: local control with external beam radiation therapy. J Urol (1979) 0.79
Experience with indwelling silicone rubber ureteral catheters. J Urol (1974) 0.79
Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study. J Urol (1975) 0.78
Have complication rates decreased after treatment for localized prostate cancer? J Urol (1999) 0.78
Prognosis in stage D-1 prostate cancer relative to anatomic sites of nodal metastases. National Prostatic Cancer Treatment Group. Cancer (1989) 0.78
Surgical management of renal lesions using in situ hypothermia and ischemia. J Urol (1976) 0.78
Oxyphenbutazone therapy for mumps orchitis, acute epididymitis and osteitis pubis. J Urol (1967) 0.78
Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. J Urol (1978) 0.78
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. J Urol (1983) 0.78
Granulomatous prostatitis: confusion clinically with carcinoma of the prostate. J Urol (1977) 0.77
Quality control of radiation therapy in multi-institutional randomized clinical trial for localized prostate cancer. Urology (1988) 0.77
Morbidity of radical perineal prostatectomy following transurethral resection of the prostate. J Urol (1984) 0.77
Urolithiasis associated with pregnancy. J Urol (1979) 0.77
Gibbons ureteral stents. Urol Clin North Am (1982) 0.77
Renal pelvic tumors. J Urol (1975) 0.77
Extracorporeal shock wave lithotripsy for obstructing pancreatic duct calculi. J Urol (1997) 0.76
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. Trans Am Assoc Genitourin Surg (1978) 0.76
A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. J Urol (1977) 0.76
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate. J Urol (1979) 0.76
The prophylactic use--or misuse--of antibiotics in transurethral prostatectomy. J Urol (1978) 0.76
The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate. Trans Am Assoc Genitourin Surg (1976) 0.76
Segmental resection in the management of bladder carcinoma. J Urol (1978) 0.75
Advances in the treatment of metastatic prostatic cancer. West J Med (1985) 0.75
Informing patients about urinary incontinence. JAMA (1999) 0.75
Re: The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol (1994) 0.75
Urology: treatment of cancer of the prostate. West J Med (1985) 0.75
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma. Urology (1976) 0.75
Prostate specific antigen detected prostate cancer. J Urol (1996) 0.75
Re: Cancer control following anatomical radical prostatectomy: an interim report. J Urol (1992) 0.75
Erythropoietin alterations in human genitourinary disease states: correlation with experimental observations. J Urol (1968) 0.75
Use of water-pik and nephroscope. Urology (1974) 0.75
Erythropoietin release associated with Wilms' tumor. Johns Hopkins Med J (1967) 0.75
Letter: Retrieval of indwelling ureteral stent. Urology (1976) 0.75
Transurethral freezing of the bladder: an experimental study. J Urol (1966) 0.75
Observations on definitive cobalt 60 radiation for cure in bladder carcinoma: 15-year followup. J Urol (1976) 0.75
Small center kidney transplantation. J Urol (1983) 0.75
Management of intrarenal vascular malformations. Urology (1973) 0.75
Experience with primary aldosteronism. J Urol (1973) 0.75
Fluid and tissue kinetics of zinc in the dog and monkey. Invest Urol (1966) 0.75
Random mucosal biopsies in the evaluation of patients with carcinoma of the bladder. J Urol (1977) 0.75
Pyeloileal urinary conduit: an 8-year experience in 37 patients. J Urol (1968) 0.75
Prostatic carcinoma. relationship between primary tumor, histologic grade, and response to chemotherapy. Urology (1976) 0.75